Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
60 participants
INTERVENTIONAL
2005-04-30
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Food Application of Okara Protein Hydrolysate (OPH)- for Anti-exercise-fatigue
NCT05000918
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)
NCT06625736
Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite
NCT01560000
The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject
NCT02410668
Flaxseed Mucilage and Satiety
NCT01238744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PhosphoLean
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chemi Nutra
UNKNOWN
The Cooper Institute
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Conrad Earnest, PhD
Role: PRINCIPAL_INVESTIGATOR
The Cooper Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Cooper Institute
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CI0151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.